About: The Fas Signaling Pathway Is a Common Genetic Risk Factor for Severe Cutaneous Drug Adverse Reactions Across Diverse Drugs

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The Fas Signaling Pathway Is a Common Genetic Risk Factor for Severe Cutaneous Drug Adverse Reactions Across Diverse Drugs Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 September 2018

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у вересні 2018 (uk) article scientifique publié en 2018 (fr) artículu científicu espublizáu en setiembre de 2018 (ast) scientific article published on 01 September 2018 (en)
publication date	wds:Q57213120-D2B8CD30-F95D-43A2-B8A6-3E4AB19DA5AB
publication date	2018-09-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q57213120-24916CA0-F2EA-477F-B776-E62F3BF460FC
language of work or name	English
cites work	wds:Q57213120-07703799-8E74-453F-A56A-19F27CBC891E wds:Q57213120-0D34D8C2-1B7B-4D5D-94FE-8E29F505A927 wds:Q57213120-11790331-EFF2-4703-B4FE-5F6633A38C2F wds:Q57213120-12697A7C-D0BC-42A8-A747-03112D682EF6 wds:Q57213120-1F63D4AE-B0FF-4DC3-B7A0-5DCD689D3A44 wds:Q57213120-21535002-68E1-410B-B4B1-7262BB3E917C wds:Q57213120-32693F34-ADCC-4B88-BE7C-86611989D84F wds:Q57213120-50D8DE1D-6A74-446A-8910-7512ABDC0FFA wds:Q57213120-51F62DEB-CA8D-4C68-A3F2-745D511E0FC5 wds:Q57213120-63C83F0F-28BC-4603-8E1E-6D24FFDB7618 wds:Q57213120-6636BA4A-D150-4649-8614-C60A4ADECD01 wds:Q57213120-71DA1371-3CB7-4A6A-9BB7-7077FB26591C wds:Q57213120-7B84DC55-F6AE-4B8F-A504-593B3245DEC3 wds:Q57213120-986717B5-108D-4F7C-959B-8037AD0C5B61 wds:Q57213120-9BC48E3F-062E-4430-B1A8-E0553033A129 wds:Q57213120-9C8A770B-BE1E-4046-A761-41CF7D6A2045 wds:Q57213120-A5B446D9-2C00-4DB7-A9D4-F754A2C996D1 wds:Q57213120-AC2A5400-0512-4C8C-8482-893C54943E98 wds:Q57213120-AC53B200-D817-4A4C-AAA9-E7912E804090 wds:Q57213120-BA72FD48-F658-44FF-8E76-23463825D89C wds:Q57213120-D3E8DDC6-F62B-4254-B6A3-2BC55C5AD653 wds:Q57213120-EB86C59C-B26A-4FA1-8053-E07A5CB52926 wds:Q57213120-EE12D7B8-BF88-4E07-9C1C-99A342E4802C
cites work	The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Toxic epidermal necrolysis and Stevens Johnson syndrome: our current understanding ConsensusPathDB--a database for integrating human functional interaction networks PLINK: a tool set for whole-genome association and population-based linkage analyses HLA-A3101 and carbamazepine-induced hypersensitivity reactions in Europeans HLA and pharmacogenetics of drug hypersensitivity. Genotype imputation for genome-wide association studies HLA-B58 can help the clinical decision on starting allopurinol in patients with chronic renal insufficiency. ConsensusPathDB: toward a more complete picture of cell biology A whole-genome association study of major determinants for allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients Ten years of pathway analysis: current approaches and outstanding challenges Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system Genome-wide association study identifies HLA-A3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population Severe cutaneous adverse drug reactions Fas (CD95/Apo-1) ligand regulation in T cell homeostasis, cell-mediated cytotoxicity and immune pathology From genome to function by studying eQTLs Genome-wide association study of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Europe Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens-Johnson syndrome: our current understanding Possible role of Fas/Fas ligand-mediated apoptosis in the pathogenesis of fixed drug eruption U.K. guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016. Cytotoxic proteins and therapeutic targets in severe cutaneous adverse reactions Pathway analysis of complex diseases for GWAS, extending to consider rare variants, multi-omics and interactions The structure and function of NKAIN2-a candidate tumor suppressor
author name string	wds:Q57213120-35AF5A5B-DFBD-4603-B7C2-ED2EF5F722B6 wds:Q57213120-3E71EDCD-174E-4A58-9366-24056BC81DF7 wds:Q57213120-5F9B691A-3FF9-429D-9AF9-B37F2B8B12BF wds:Q57213120-831E6A35-B796-4E47-8024-DF01BCA68789 wds:Q57213120-8AAFF02B-AC67-49C4-8366-5D494436AA91
author name string	Sang Hoon Kim Sang Heon Kim Ai Young Lee In Jin Jang Kyung Up Min
rdfs:label	The Fas Signaling Pathway Is a Common Genetic Risk Factor for Severe Cutaneous Drug Adverse Reactions Across Diverse Drugs (en) The Fas Signaling Pathway Is a Common Genetic Risk Factor for Severe Cutaneous Drug Adverse Reactions Across Diverse Drugs (nl)
skos:prefLabel	The Fas Signaling Pathway Is a Common Genetic Risk Factor for Severe Cutaneous Drug Adverse Reactions Across Diverse Drugs (en) The Fas Signaling Pathway Is a Common Genetic Risk Factor for Severe Cutaneous Drug Adverse Reactions Across Diverse Drugs (nl)
name	The Fas Signaling Pathway Is a Common Genetic Risk Factor for Severe Cutaneous Drug Adverse Reactions Across Diverse Drugs (en) The Fas Signaling Pathway Is a Common Genetic Risk Factor for Severe Cutaneous Drug Adverse Reactions Across Diverse Drugs (nl)
author	wds:Q57213120-1C5F4E6C-C058-464F-9A35-650E1024DFA1 wds:Q57213120-7838FBD7-AEFA-466F-98CC-9C16F150C255 wds:Q57213120-AF0B6E54-91C2-4D3C-9FD3-082D58471900 wds:Q57213120-D5F9EB6C-49F6-4A87-8FD4-564A29F0ACED
author	Hae-Sim Park Yoon-Seok Chang Heung-Woo Park Young-koo Jee
title	wds:Q57213120-0C480949-B77C-4AE7-91EE-0B8F36DD2830
title	The Fas Signaling Pathway Is a Common Genetic Risk Factor for Severe Cutaneous Drug Adverse Reactions Across Diverse Drugs (en)
page(s)	wds:Q57213120-C8DD83F1-B172-4F6C-B431-45E8F11DFF05
page(s)	555-561
instance of	wds:Q57213120-F79899E2-4513-44D1-99D0-8CC8930BEC62
instance of	scholarly article
main subject	wds:Q57213120-4ADBA9B7-50F2-4890-B042-3D985A9F9A10
main subject	immunology
PubMed ID	wds:Q57213120-63DDCB7A-A0DE-4870-B402-ACF3A3D7EDF8
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30088374
PubMed ID	30088374
published in	wds:Q57213120-28DBF00D-DB9C-45C5-8135-E5BD8DA21275
published in	Allergy, Asthma & Immunology Research
issue	wds:Q57213120-08B37CFC-CD40-4D48-8981-78A77B5CD49D
volume	wds:Q57213120-A2DE0B8D-21C5-487E-A407-2B121D4AEF35
issue	5
volume	10
DOI	wds:Q57213120-AEECC838-079A-4FB3-A5D3-3F1C7F9AE333
DOI	http://dx.doi.org/10.4168/AAIR.2018.10.5.555
DOI	10.4168/AAIR.2018.10.5.555

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software